Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.51 |
| ▸ | CA1 | P00915 | 3/20 | 0.51 |
| ▸ | CNR1 | P21554 | 4/20 | 0.50 |
| ▸ | MMP2 | P08253 | 5/20 | 0.43 |
| ▸ | MMP3 | P08254 | 5/20 | 0.43 |
| ▸ | MMP1 | P03956 | 3/20 | 0.43 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.43 |
| ▸ | MMP7 | P09237 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL745017 | 0.84 | CA2 (0.56) | CA2CA1MMP2MMP3MMP1 | |
| SCHEMBL7982671 | 0.83 | CNR1 (0.64) | CA1CNR1MAPK1KCNK3ALDH1A1 | |
| SCHEMBL7992939 | 0.83 | CNR1 (0.64) | CA1CNR1MAPK1KCNK3ALDH1A1 | |
| SCHEMBL2058865 | 0.82 | CA2 (0.63) | CA2CA1MMP2MMP3MMP1 | |
| SCHEMBL5901979 | 0.80 | FAAH (0.55) | CA2CA1MMP2MMP3MMP1 | |
| SCHEMBL29063421 | 0.78 | BIRC2 (0.70) | CA2CA1MMP2MMP3MMP1 | |
| SCHEMBL20656646 | 0.77 | CA2 (0.61) | CA2CA1MAPK1ALDH1A1 | |
| SCHEMBL11095965 | 0.77 | CA2 (0.66) | CA2CA1MAPK1ALDH1A1 | |
| SCHEMBL20915578 | 0.77 | CA2 (0.85) | CA2CA1MMP2MMP3MMP1 | |
| SCHEMBL20915508 | 0.77 | CA2 (0.85) | CA2CA1MMP2MMP3MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009126502-A2 | METHODS OF INHIBITING AND TREATING BIOFILMS USING GLYCOPEPTIDE ANTIBIOTICS | TARGANTA THERAPEUTICS CORP. (US) | 2009-10-15 | — | — | WO | disclosed |